Skip to content
Recall Observatory FDA recall evidence

Drug product

Erythromycin Topical Gel USP, 2%, Net Wt 30 g tube, Rx only, Manufactured by: Teligent Pharma, Inc., Buena, NJ 08310, Distributed by: McKesson Corporation, dba Sky Packaging, 4971 Southridge Blvd., Suite 101, Memphis, TN 38141, NDC 63739-053-66.

D-0716-2022

February 07, 2022

Class II

Product summary

Firm
Teligent Pharma, Inc.
Event
Event 89560
Status
Terminated
Classification
Class II
Quantity
11040 tubes
Official record key
drug-enforcement:D-0716-2022

Official wording

Reason: Failed Impurities/Degradation Specifications: Lot not meeting specification for Unknown Max Related Compounds.

Code information: Lot: 15724, Exp. 06/2022

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications